U.S., Sept. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07182058) titled 'Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms' on Sept. 16.
Brief Summary: This study tests a new, non-invasive brain stimulation device called Sphere V3.0 to help improve movement problems in people with Parkinson's disease. The device delivers gentle electrical signals to the scalp using small electrodes placed on the head.
Participants will use the device at home for 13 minutes each weekday (Monday through Friday) for 3 weeks, then be monitored for another 3 weeks without treatment. The entire study lasts 6 weeks and is conducted virtually through video calls and online assessments.
We will measure change...